ESC: Cumulative Sedentary Time in Younger Years Tied to Changes in Heart Structure
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 31, 2023 -- Cumulative increases in sedentary time during growth from childhood through young adulthood are associated with progressive left ventricular structural remodeling, according to a study presented at the European Society of Cardiology Congress 2023, held from Aug. 25 to 28 in Amsterdam.
Andrew O. Agbaje, M.D., M.P.H., from University of Eastern Finland in Kuopio, and colleagues examined the longitudinal association of cumulative sedentary time from childhood through young adulthood on structural cardiac changes during growth from adolescence through young adulthood. The analysis included 766 children (aged 11 years) from the U.K. Children of the 90s study who had at least two follow-up timepoints with accelerometer-measured sedentary time during 13 years of follow-up. Sedentary time was assessed at 11, 15, and 24 years. Echocardiography was done at baseline and follow-up.
The researchers found that a one-minute increase in sedentary time from ages 11 to 24 years was associated with progressively increased changes in left ventricular mass indexed for height2.7 (effect estimate, 0.004 g/m2.7; P = 0.002) from ages 17 to 24 years overall and among females (effect estimate, 0.009 g/m2.7; P < 0.0001). Over time, there was not a significant association between cumulative sedentary time and changes in relative wall thickness in the total cohort or among males or females.
“All those hours of screen time in young people add up to a heavier heart, which we know from studies in adults raises the likelihood of heart attack and stroke,” said Agbaje in a statement. “Children and teenagers need to move more to protect their long-term health.”
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.